The recent disruptions in global chains have highlighted the necessity of securing critical medications like Ivermectin. Relying on overseas manufacturers exposes regions to considerable vulnerabilities, including shipping delays, cost fluctuations, and even trade risks. Moving towards domestic sourcing of Ivermectin offers a multitude of advantage